Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M45.5Revenue $M42.5Net Margin (%)24.8Z-Score2.8
Enterprise Value $M39.7EPS $1.4Operating Margin %30.6F-Score5
P/E(ttm))3.8Cash Flow Per Share $2.2Pre-tax Margin (%)30.4Higher ROA y-yY
Price/Book0.410-y EBITDA Growth Rate %0Quick Ratio2.7Cash flow > EarningsN
Price/Sales0.95-y EBITDA Growth Rate %-8.5Current Ratio3.7Lower Leverage y-yY
Price/Cash Flow0.8y-y EBITDA Growth Rate %70.2ROA % (ttm)7.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)9.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M7.6ROI % (ttm)6.1Gross Margin Increase y-yN

Gurus Latest Trades with SKBI

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

SKBI is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


SKBI: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about SKBI :

    Quarterly/Annual Reports about SKBI:

    News about SKBI:

    Articles On GuruFocus.com
    animal vaccination w Oct 11 2011 

    More From Other Websites
    Skystar Bio-Pharmaceutical Reports Second Quarter Fiscal Year 2014 Financial Results Aug 15 2014
    Skystar Bio-Pharmaceutical to File Financial Results for Second Quarter of Fiscal 2014 on Thursday,... Aug 15 2014
    Skystar Bio-Pharmaceutical Reports Second Quarter Fiscal Year 2014 Financial Results Aug 14 2014
    Skystar Bio-Pharmaceutical to File Financial Results for Second Quarter of Fiscal 2014 on Thursday,... Aug 14 2014
    SKYSTAR BIO-PHARMACEUTICAL CO Files SEC form 10-Q, Quarterly Report Aug 14 2014
    SKYSTAR BIO-PHARMACEUTICAL CO Files SEC form 8-K, Material Modification to Rights of Security... Jul 21 2014
    Skystar Bio-Pharmaceutical Announces $5 Million Registered Direct Offering Jul 16 2014
    SKYSTAR BIO-PHARMACEUTICAL CO Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jul 16 2014
    Skystar Bio-Pharmaceutical Announces $5 Million Registered Direct Offering Jul 16 2014
    Skystar Launches Bovine Immunoglobulin G (IgG) Kits in China Jul 09 2014
    Skystar Bio-Pharma launches bovine immunoglobulin G kits in China Jul 08 2014
    Skystar Launches Bovine Immunoglobulin G (IgG) Kits in China Jul 08 2014
    SKYSTAR BIO-PHARMACEUTICAL CO Financials May 23 2014
    Skystar Bio-Pharmaceutical's (SKBI) CEO Weibing Lu on Q1 2014 Results - Earnings Call Transcript May 16 2014
    Skystar Bio-Pharmaceutical Reports First Quarter Fiscal Year 2014 Financial Results May 15 2014
    SKYSTAR BIO-PHARMACEUTICAL CO Files SEC form 10-Q, Quarterly Report May 15 2014
    Skystar Bio-Pharmaceutical to File Financial Results for First Quarter of Fiscal 2014 on Thursday,... May 15 2014
    Skystar Bio-Pharmaceutical Provides Update to Its Patent Portfolio Apr 17 2014
    SKYSTAR BIO-PHARMACEUTICAL CO Files SEC form 8-K, Other Events Apr 16 2014
    Skystar Bio Pharmaceutical Company: Undervalued With A Strong Growth Catalyst Apr 15 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide